Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma

Naoya Mimura, Mariateresa Fulciniti, Gullu Gorgun, Yu Tzu Tai, Diana Cirstea, Loredana Santo, Yiguo Hu, Claire Fabre, Jiro Minami, Hiroto Ohguchi, Tanyel Kiziltepe, Hiroshi Ikeda, Yutaka Kawano, Maureen French, Martina Blumenthal, Victor Tam, Nathalie L. Kertesz, Uriel M. Malyankar, Mark Hokenson, Tuan PhamQingping Zeng, John B. Patterson, Paul G. Richardson, Nikhil C. Munshi, Kenneth C. Anderson

Research output: Contribution to journalArticlepeer-review

304 Scopus citations

Fingerprint

Dive into the research topics of 'Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds